Dr. Peter Kaiser’s lab at UC Irvine studies two major areas: how cells communicate environmental signals through ubiquitin signaling and the reactivation of mutant p53 proteins in cancer. By examining metabolism and its effects on the cell cycle, as well as developing therapies for cancer that target p53, the lab aims to uncover important mechanisms underlying cell growth, disease, and potential treatments.

Dr. Seyed Ali Mortazavi's lab focuses on understanding the influence of genetic variants on gene expression and functionality in mouse models. By analyzing diverse mouse strains at the single-cell level, the lab aims to create a comprehensive resource that maps how these variants affect different cell types across various tissues. This research is crucial for developing better models of human diseases and for enhancing our understanding of genetics in health and complex diseases.

Roberto Tinoco's lab at UC Irvine focuses on understanding how specific proteins regulate T cell responses during chronic viral infections like HIV and HCV. The research aims to uncover the mechanisms by which T cells become exhausted and explore potential therapies to reinvigorate these immune cells. Overall, the lab seeks to enhance our understanding of T cell behavior and develop new treatment approaches for chronic infections and cancers.

Dr. Kyriacos A. Athanasiou's lab at UC Irvine focuses on developing innovative treatments for injuries related to the temporomandibular joint (TMJ). They are exploring the use of engineered tissue implants, specifically neodisc constructs, that incorporate immune cells to enhance healing and reduce rejection by the body. This multidisciplinary approach aims to solve a pressing medical issue affecting millions and could lead to advancements in tissue engineering beyond TMJ applications.

Dr. Bruce Blumberg's lab at UC Irvine focuses on understanding how prenatal exposure to environmental chemicals, particularly endocrine disruptors, affects obesity in future generations. They study mechanisms of epigenetic inheritance, which could explain how these effects are passed down without changes to DNA. This research aims to uncover how these inherited traits lead to metabolic diseases and how interventions might prevent these transgenerational effects.

Dr. Lan Huang's lab focuses on understanding how proteins interact within cells, specifically looking at a system known as the ubiquitin-proteasome system that helps manage protein degradation. By advancing new technologies in mass spectrometry, the lab aims to unravel the complex networks of these protein interactions to shed light on their roles in diseases such as cancer and neurodegenerative disorders. This research could lead to new therapies that target these vital biological processes.

Professor Lisa Wagar's lab at UC Irvine focuses on understanding the immune responses to influenza viruses. Using a novel approach with human tonsil organoids, the lab investigates how different features of the host and the virus influence the effectiveness of immune responses. Their ultimate goal is to aid in the development of a universal influenza vaccine that could provide better protection against various influenza strains.

Dr. Szu-Wen Wang's lab focuses on creating innovative vaccine platforms using advanced materials science to improve immune responses against influenza and other rapidly changing viruses. By optimizing vaccine delivery and presentation with nanotechnology, the lab aims to enhance the effectiveness and durability of immune protection after a single vaccination. This research has the potential to respond quickly to new infectious threats and contribute to public health by advancing vaccine technology.

Dr. Shawn Xiang's research lab at the University of California, Irvine focuses on advancing proton therapy for cancer treatment through innovative imaging technologies. The lab is developing new methods to accurately map the Bragg peak—where proton therapy is most effective—using protoacoustic and ultrasound imaging. This research aims to improve treatment precision, enhance patient safety, and facilitate clinical adoption of new dosimetry techniques. By integrating these imaging systems, the lab seeks to push the boundaries of radiation oncology and reduce side effects of treatment for patients.

Dr. Xiangmin Xu's lab focuses on understanding how aging and Alzheimer's disease (AD) affect brain circuits and cellular functions. They use advanced mouse models and cutting-edge techniques to investigate the molecular mechanisms that lead to cognitive deficits in AD. Through their work, the lab aims to create better diagnostic tools and treatment strategies for this debilitating condition.

Dr. Michael Yassa's lab at UC Irvine focuses on unraveling the complexities of memory and its impact on mental health and neurodegenerative diseases. Research in the lab investigates conditions like anhedonia—a loss of pleasure—by exploring its relationship with memory processing and neural circuitry. The lab also examines how cerebrovascular health affects Alzheimer’s disease progression, especially in minority populations, aiming to develop predictive biomarkers that can guide interventions and improve clinical outcomes.

The research lab led by Dr. Jing Zhang focuses on integrating advanced computational methods and genomic techniques to understand complex diseases like Alzheimer’s and the impacts of opioid use in people living with HIV. Their work involves studying molecular changes at the single-cell level, employing innovative artificial intelligence approaches, and validating findings through cutting-edge genomic technologies. This interdisciplinary lab aims to pioneer new insights into the interconnectedness of genetics, epigenetics, and disease mechanisms.